CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenue
Total revenue, net	$ 2,979	$ 2,721	$ 5,193	$ 5,072
Operating expenses
Cost of product revenue	527	427	1,042	857
Research and development	3,265	3,653	6,995	7,965
Sales and marketing	2,467	1,524	4,960	2,967
General and administrative	4,727	4,314	9,624	8,695
Total operating expenses	10,986	9,918	22,621	20,484
Loss from operations	(8,007)	(7,197)	(17,428)	(15,412)
Gain (loss) on extinguishment of debt	(1,822)		(1,822)	1,245
Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option	(1,068)	(1,810)	(2,411)	(3,831)
Interest income (expense)	15	108	71	(503)
Other income (expense)	322	(729)	434	(495)
Loss before income tax expense	(10,560)	(9,628)	(21,156)	(18,996)
Net loss	(10,560)	(9,628)	(21,156)	(18,996)
Net loss attributable to noncontrolling interest	(153)	(136)	(285)	(278)
Net loss attributable to common stockholders	$ (10,407)	$ (9,492)	$ (20,871)	$ (18,718)
Net loss per share, basic	$ (10.26)	$ (2.66)	$ (26.78)	$ (7.8)
Net loss per share, diluted	$ (10.26)	$ (2.66)	$ (26.78)	$ (7.8)
Weighted-average common stock outstanding, basic	1,014,783	3,572,984	779,391	2,398,269
Weighted-average common stock outstanding, diluted	1,014,783	3,572,984	779,391	2,398,269
Product revenue, net
Revenue
Total revenue, net	$ 2,936	$ 2,678	$ 5,107	$ 5,029
License revenue
Revenue
Total revenue, net	$ 43	$ 43	$ 86	$ 43